Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 October 2021 | Story Dr Nitha Ramnath | Photo Rhona Klopper
Donating masks to Rekopane Primary School, were from the left: Alfi Moolman (UFS Directorate: Community Engagement), Sonja Venter-Botes (Bloemshelter), Tina Moleko (Rankwe Primary School), and Michelle Engelbrecht (UFS Centre for Health Systems Research and Development).


The Centre for Health Systems Research and Development (CHSR&D) at the University of the Free State (UFS) recently donated 500 masks to Rekopane Primary School in Botshabelo. This initiative was part of its pledge to donate 100 cloth masks to a previously disadvantaged primary school for every 1 000 of the first 5 000 completed questionnaires that formed part of a study survey examining people’s understanding of information about COVID-19 vaccines. The results of the study will be shared with stakeholders who are responsible for providing information about COVID-19 vaccinations.

It is known that a large number of people globally and in South Africa prefer not to be vaccinated. “There are many reasons for this, and we would like to find out where people are getting information about the COVID-19 vaccination, and whether they are able to understand this information, so that they can make an informed choice about getting vaccinated. We did this by asking people about their own health and COVID-19, where they have heard about the vaccine, if they understood this information, and whether they have had/would have the vaccine or not, as well as the reasons for this,” said Prof Michelle Engelbrecht, Director of CHSR&D. 

While following guidelines such as wearing masks, sanitising hands, and social distancing are important to prevent the spread of COVID-19, a large percentage of the population will need to be vaccinated if we want to control the pandemic in the long term and prevent hospitalisation and severe illness. 

All persons in South Africa aged 18 and older were invited to complete an online survey regarding their perceptions of COVID-19 vaccines. The survey, which was available in the seven most spoken languages in the country, was advertised on social media platforms such as Facebook and Twitter, and on the Moya app.  The survey was open from 1 to 31 September 2021, and the CHSR&D received 10 554 completed questionnaires.  No data was required to complete the survey.

The Department of Basic Education partners decided on the school that would benefit, and the study provided an opportunity to support Bloemshelter, a UFS flagship programme. Alfi Moolman of the Directorate: Community Engagement said that “NGOs are really struggling to make ends meet, and we are delighted that Bloemshelter could provide the masks as one of their income-generating projects.  So many lives are touched for the good. The university is indeed a caring organisation.”


News Archive

UFS researcher explores the future cost of cancer
2017-01-10

 Description: 001 Dr Alicia Sherriff Tags: 001 Dr Alicia Sherriff

Dr Alicia Sherriff, Head the Department of Oncology
at the UFS Faculty of Health Sciences, co-authored
an article in the South African Medical Journal.

Photo: Charl Devenish

Cancer is on an exponential rise globally, and the cost of treatment is a growing international problem. South Africa alone is expected to see a 78% increase in cancer cases. Dr Alicia Sheriff, Head of the Department of Oncology, collaborated on and co-authored a research paper for the South African Medical Journal on the future of oncology treatment in the country, along with doctors from various universities across South Africa. The article, titled "The future cost of cancer: interdisciplinary cost management strategy", looks at the prognosis of cancer management in the country.

Cancer is on the rise

There is a visible growth of the cancer disease in the developing world. Rapidly changing lifestyles, uncontrolled urbanisation, pollution, and population ageing are some dynamics that provide a lethal cocktail of infectious and lifestyle risk factors that leave people at a higher risk of developing cancer.

The simultaneous increase in cancer incidence has increased the cost of treatment exponentially. The cost of cancer treatment is multitiered, making the provision of care for cancer patients a high-risk business. A combination of treatment delays, limited resources, differently skilled personnel, high patient volumes and advanced disease stage on presentation all place a bigger burden on the delivery of optimal cancer care outcomes.

Adoption of new strategies

According to the doctors, innovative thinking to embrace technology, combined with a preventive approach, as well as lowering the cost of treatment drugs should be prioritised. So should the commercialisation of new technologies that will diagnose and treat cancer in its early stages. They also encourage interdisciplinary research funding in South Africa as a way to better understand the demographic and molecular dynamics of cancer in the country, along with retaining more oncologists in the public health sector.

Efficient solutions to curb cancer mortality

The doctors assert there is a need to continue to look for more efficient measures to best treat the disease, and hopefully bring about a change in mortality levels in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept